In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...
Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...
At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...
Northwestern scientists said they found pancreatic cancer cells play a trick on a person's immune system by wearing a sugar ...
XNCR pairs a wholly owned antibody pipeline with XmAb platform partnerships. This way, they get milestones, licensing revenue ...
A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...
The ninth known case of welder’s anthrax, and the first clinical use of the monoclonal antibody medication obiltoxaximab to ...
And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...
Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.
The top news to come out of skin cancer coverage this year for MHE focused on blood or marrow transplant recipients ...
NewsNation on MSN
UT researchers develop antibody modification technique that could change how viruses are treated
Researchers at Texas Biologics at The University of Texas at Austin recently made a discovery that they believe could ...
Elanco Receives USDA Approval for Befrena (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis. News release. Elanco Animal Health. December 31, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback